Organogenesis Holdings Stock In The News
| ORGO Stock | USD 3.90 0.06 1.52% |
Our overall analysis of Organogenesis Holdings' news coverage and content from conventional and social sources shows investors' bearish mood towards Organogenesis Holdings. The specific impact of Organogenesis Holdings news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Organogenesis Holdings' overall financial health and prospects. It also depends on the type and quality of a news publisher.
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Organogenesis Holdings headlines in addition to utilizing other, more conventional financial analysis modules. Check out Organogenesis Holdings Backtesting and Organogenesis Holdings Hype Analysis. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.
Organogenesis |
Organogenesis Holdings Today Top News and Investor Outlook
Organogenesis Holdings Past News Timeline
Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Organogenesis and other traded companies coverage with news coverage. We help investors stay connected with Organogenesis headlines for the 28th of November to make an informed investment decision based on correlating the impacts of news items on Organogenesis Stock performance. Please note that trading solely based on the Organogenesis Holdings hype is not for everyone as timely availability and quick action are needed to avoid losses.
Organogenesis Holdings stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Organogenesis earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Organogenesis Holdings that are available to investors today. That information is available publicly through Organogenesis media outlets and privately through word of mouth or via Organogenesis internal channels. However, regardless of the origin, that massive amount of Organogenesis data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Organogenesis Holdings news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Organogenesis Holdings relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Organogenesis Holdings' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Organogenesis Holdings alpha.
Organogenesis Largest EPS Surprises
Earnings surprises can significantly impact Organogenesis Holdings' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-05-09 | 2024-03-31 | -0.03 | -0.02 | 0.01 | 33 | ||
2023-11-09 | 2023-09-30 | 0.01 | 0.02 | 0.01 | 100 | ||
2023-08-09 | 2023-06-30 | 0.03 | 0.04 | 0.01 | 33 | ||
2023-03-01 | 2022-12-31 | 0.05 | 0.06 | 0.01 | 20 | ||
2022-08-09 | 2022-06-30 | 0.08 | 0.07 | -0.01 | 12 | ||
2024-02-29 | 2023-12-31 | 0.01 | -0.0043 | -0.0143 | 143 |
Organogenesis Holdings Stock Latest Headlines
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Organogenesis Holdings Stock. Current markets are slightly bullish. About 55% of major world exchanges and indexes are currently up. See today's market update for more information.
22nd of November 2024
Organogenesis Expands Manufacturing Capacity to Support Future Growth at gurufocus.com
15th of November 2024
Organogenesis Commends Final LCDs at globenewswire.com
13th of November 2024
Organogenesis Holdings Inc Q3 2024 Earnings Call Highlights Strong Revenue Growth Amid ... at gurufocus.com
12th of November 2024
Organogenesis announces 130M private placement offering at seekingalpha.com
5th of November 2024
Bioventus Matches Q3 Earnings Estimates at zacks.com
15th of October 2024
Organogenesis Shows Fast-paced Momentum But Is Still a Bargain Stock at zacks.com
16th of September 2024
Wealth Dimensions Group Ltd. Grows Stock Holdings in Organogenesis Holdings Inc. - MarketB... at news.google.com
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Organogenesis Holdings in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Organogenesis Holdings' short interest history, or implied volatility extrapolated from Organogenesis Holdings options trading.
Check out Organogenesis Holdings Backtesting and Organogenesis Holdings Hype Analysis. To learn how to invest in Organogenesis Stock, please use our How to Invest in Organogenesis Holdings guide.You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Organogenesis Holdings. If investors know Organogenesis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Organogenesis Holdings listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 3.5 | Earnings Share (0.05) | Revenue Per Share 3.446 | Quarterly Revenue Growth 0.061 | Return On Assets 0.0164 |
The market value of Organogenesis Holdings is measured differently than its book value, which is the value of Organogenesis that is recorded on the company's balance sheet. Investors also form their own opinion of Organogenesis Holdings' value that differs from its market value or its book value, called intrinsic value, which is Organogenesis Holdings' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Organogenesis Holdings' market value can be influenced by many factors that don't directly affect Organogenesis Holdings' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Organogenesis Holdings' value and its price as these two are different measures arrived at by different means. Investors typically determine if Organogenesis Holdings is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Organogenesis Holdings' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.